High Infectious Diseases Incidence Drives the Indian Anti-Infective Pharma Market03 Oct 2011 • by Natalie Aster
Mumbai – The biggest contributor to domestic pharmaceutical sales in India is anti-infective pharmaceuticals market, contributing around 18%. The Indian market is characterized by a tremendous demand for anti-infective drugs, since India has an extensive patient pool. It is a highly fragmented market with a huge number of foreign and domestic players. The large expansion in the patient population, increasing number of vaccine approvals, boost in health insurances and introduction of newer and better drugs is helping the market to grow. The Indian Government, on its part, has introduced some control programmes, undertaken various Private Partnership Projects (PPP) and has taken initiatives to reduce drug prices. The market is expected to exhibit steady growth over the next few years.
Netscribes (India) Pvt. Ltd., a knowledge consulting solutions company, announces the launch of the report “Anti-Infective Pharmaceuticals Market in India 2011”.
Published: September 2011
Price: US$ 475.00
Indian Market – Overview:
- Anti-infectives belong to the acute segment which makes up around z% of the total pharmaceutical industry. Cephalosporins, penicillins and quinolones are key drug classes among anti-infectives, with a share of around z% of the country’s anti-infectives market;
- Presently the market has a size of INR X bn, and is expected to grow at a CAGR of x% from 20--;
- In 2010 GSK’s Augmentin was the highest selling drug. Zifi, Taxim ,Monocef, Mox, Taxim-O , Zinacef and Gerimac were the other top selling drugs;
- India has emerged as one of the leading vaccine manufacturer in recent times, producing z% of the global health vaccines. Pentaxim, Varivax and Prevenar were the top selling vaccines in 20--.
Market Size and Growth
Top Pharmaceutical Segments - 2010
- Highly fragmented market with large number of players;
- Major foreign players in the market include Gilead Inc, Abbott, Glaxosmithkline etc;
- Major domestic companies include Ranbaxy, Cipla, Dr. Reddy’s, Sun Pharmaceuticals, Panacea Biotech, Torrent Pharmaceuticals among others.
More information can be found in the report “Anti-Infective Pharmaceuticals Market in India 2011” by Netscribes (India) Pvt. Ltd.
To order the report or ask for sample pages contact firstname.lastname@example.org
Tel: +44 208 144 6009
Fax: +44 207 900 3970